These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 17243893)

  • 21. Interferon interplay helps tissue cells to cope with SARS-coronavirus infection.
    Kuri T; Weber F
    Virulence; 2010; 1(4):273-5. PubMed ID: 21178452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice.
    Nagata N; Iwata N; Hasegawa H; Fukushi S; Harashima A; Sato Y; Saijo M; Taguchi F; Morikawa S; Sata T
    Am J Pathol; 2008 Jun; 172(6):1625-37. PubMed ID: 18467696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry.
    He Y; Zhou Y; Siddiqui P; Jiang S
    Biochem Biophys Res Commun; 2004 Dec; 325(2):445-52. PubMed ID: 15530413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.
    Ou X; Liu Y; Lei X; Li P; Mi D; Ren L; Guo L; Guo R; Chen T; Hu J; Xiang Z; Mu Z; Chen X; Chen J; Hu K; Jin Q; Wang J; Qian Z
    Nat Commun; 2020 Mar; 11(1):1620. PubMed ID: 32221306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.
    See RH; Zakhartchouk AN; Petric M; Lawrence DJ; Mok CPY; Hogan RJ; Rowe T; Zitzow LA; Karunakaran KP; Hitt MM; Graham FL; Prevec L; Mahony JB; Sharon C; Auperin TC; Rini JM; Tingle AJ; Scheifele DW; Skowronski DM; Patrick DM; Voss TG; Babiuk LA; Gauldie J; Roper RL; Brunham RC; Finlay BB
    J Gen Virol; 2006 Mar; 87(Pt 3):641-650. PubMed ID: 16476986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection.
    Liu L; Wei Q; Lin Q; Fang J; Wang H; Kwok H; Tang H; Nishiura K; Peng J; Tan Z; Wu T; Cheung KW; Chan KH; Alvarez X; Qin C; Lackner A; Perlman S; Yuen KY; Chen Z
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.
    Frieman MB; Chen J; Morrison TE; Whitmore A; Funkhouser W; Ward JM; Lamirande EW; Roberts A; Heise M; Subbarao K; Baric RS
    PLoS Pathog; 2010 Apr; 6(4):e1000849. PubMed ID: 20386712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus.
    Zielecki F; Weber M; Eickmann M; Spiegelberg L; Zaki AM; Matrosovich M; Becker S; Weber F
    J Virol; 2013 May; 87(9):5300-4. PubMed ID: 23449793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection.
    Chen J; Lau YF; Lamirande EW; Paddock CD; Bartlett JH; Zaki SR; Subbarao K
    J Virol; 2010 Feb; 84(3):1289-301. PubMed ID: 19906920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation.
    Beirag N; Kumar C; Madan T; Shamji MH; Bulla R; Mitchell D; Murugaiah V; Neto MM; Temperton N; Idicula-Thomas S; Varghese PM; Kishore U
    Front Immunol; 2022; 13():960733. PubMed ID: 35967323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry.
    Han DP; Lohani M; Cho MW
    J Virol; 2007 Nov; 81(21):12029-39. PubMed ID: 17715238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.
    Yi C; Sun X; Ye J; Ding L; Liu M; Yang Z; Lu X; Zhang Y; Ma L; Gu W; Qu A; Xu J; Shi Z; Ling Z; Sun B
    Cell Mol Immunol; 2020 Jun; 17(6):621-630. PubMed ID: 32415260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-β and IFN inducer.
    Shuai H; Chu H; Hou Y; Yang D; Wang Y; Hu B; Huang X; Zhang X; Chai Y; Cai JP; Chan JF; Yuen KY
    J Infect; 2020 Oct; 81(4):e1-e10. PubMed ID: 32707230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.
    Sims AC; Burkett SE; Yount B; Pickles RJ
    Virus Res; 2008 Apr; 133(1):33-44. PubMed ID: 17451829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice.
    Channappanavar R; Fehr AR; Vijay R; Mack M; Zhao J; Meyerholz DK; Perlman S
    Cell Host Microbe; 2016 Feb; 19(2):181-93. PubMed ID: 26867177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
    Roehrich H; Yuan C; Hou JH
    Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of interferon-gamma-inducible protein 10 by SARS-CoV infection, interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3 cells and BALB/c mice.
    Kumaki Y; Day CW; Bailey KW; Wandersee MK; Wong MH; Madsen JR; Madsen JS; Nelson NM; Hoopes JD; Woolcott JD; McLean TZ; Blatt LM; Salazar AM; Smee DF; Barnard DL
    Antivir Chem Chemother; 2010 Mar; 20(4):169-77. PubMed ID: 20231782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus.
    Kuhn JH; Li W; Choe H; Farzan M
    Cell Mol Life Sci; 2004 Nov; 61(21):2738-43. PubMed ID: 15549175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection.
    Tseng CT; Perrone LA; Zhu H; Makino S; Peters CJ
    J Immunol; 2005 Jun; 174(12):7977-85. PubMed ID: 15944304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model.
    Ishii K; Hasegawa H; Nagata N; Ami Y; Fukushi S; Taguchi F; Tsunetsugu-Yokota Y
    Microbiol Immunol; 2009 Feb; 53(2):75-82. PubMed ID: 19291090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.